Treatment of post-myocardial infarction depressive disorder

Expert Review of Neurotherapeutics

Volumn 8, Issue 7, 2008, Pages 1115-1123

  Kuyper, Astrid M G ^a,b   Honig, Adriaan ^a  

^a ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Antide pressive treatment; Depressive disorder; Post myocardial infarction; Randomized controlled trial

Indexed keywords

CITALOPRAM; FLUOXETINE; MIRTAZAPINE; PLACEBO; POLYUNSATURATED FATTY ACID; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

BECK DEPRESSION INVENTORY; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; COMORBIDITY; CORONARY ARTERY DISEASE; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAPHY; EXHAUSTION; HEALTH BEHAVIOR; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HOSTILITY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; INFLAMMATION; ISCHEMIC HEART DISEASE; MENTAL FUNCTION; MORTALITY; OUTCOME ASSESSMENT; PATHOGENESIS; PATHOPHYSIOLOGY; PERSONALITY; PROGNOSIS; PSYCHOTHERAPY; QUALITY OF LIFE; QUESTIONNAIRE; REMISSION; REVIEW; SCORING SYSTEM; SOCIAL PSYCHOLOGY; THROMBOCYTE ACTIVATION; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

DEPRESSIVE DISORDER; HUMANS; MYOCARDIAL INFARCTION;

EID: 46949094963     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.8.7.1115     Document Type: Review

References (34)

1. Strik JMH, Lousberg R, Cherieux EC, Honig A. One year cumulative incidence of depression after myocardial infarction and impact on cardiac outcome. J. Psychosom. Res. 56, 59-66 (2004).
2. Melle JP, van de Jonge P, Spijkerman TA et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom. Med. 66, 814-822 (2004).
3. Penninx BWJH, Beekman ATF, Honig A et al. Depression and cardiac mortality. Arch. Gen. Psychiatry 58, 221-227 (2001).
4. McGovern PG, Pankow JS, Shahar E et al. Recent trends in acute coronary heart disease: mortality, morbidity, medical care, and risk factors. N. Engl. J. Med. 334, 884-890(1996).
5. Rapaport MH, Judd LL, Shettler PJ et al. A descriptive analysis of minor depression. Am. J. Psychiatry 159, 637-643 (2002).
6. Frasure-Smith N, Lespérance F, Talajic M. Depression following myocardial infarction: impact on 6-month survival. JAMA 270, 1819-1825 (1993).
7. Berkman LF, Leo-Summers L, Horwitz RI. Emotional support and survival after myocardial infarction: a prospective, population-based study of the elderly. Ann. Intern. Med. 117, 1003-1009 (1992).
8. Case RB, Moss AJ, Case N, McDermott M, Eberly S. Living alone after myocardial infarction. JAMA 267, 515-519 (1992).
9. de Jonge P, Spijkerman TA, van den Brink RHS, Ormel J. Depression following myocardial infarction is a risk factor for declined health-related quality of life and increased disability and cardiac complaints at 12 months. Heart 92, 32-39 (2006).
10. Carney RM, Blumenthal JA, Freedland KE et al.; for the ENRICHD Investigators. Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) Study. Psychosom. Med. 66, 466-474(2004).
11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th Edition. American Psychiatric Association, Washington, DC, USA (1994).
12. Strik JMH, Honig A, Lousberg R, Denollet J. Sensitivity and specificity of observer and self-report questionnaires in major and minor depression following myocardial infarction. Psychosomatics 42, 423-428 (2001).
13. van Melle JP, de Jonge P, Ormel J et al.; for the MIND-IT investigators. Relationship between left ventricular dysfunction and depression following myocardial infarction: data from the MIND-IT Eur. Heart J. 26, 2650-2656 (2005).
14. de Jonge P, Ormel J, van den Brink RHS et al. Symptom dimensions of depression following myocardial infarction and their relationship with somatic health status and cardiovascular prognosis. Am. J. Psychiatry 163, 138-144 (2006).
15. Wojciechowski FL, Strik JJMH, Falger P, Lousberg R, Honig A. The relationship between depressive and vital exhaustion symptomatology pot-myocardial infarction. Acta Psychiatrica Scand. 102, 359-365 (2000).
16. Emons WH, Meijer RR, Denollet J. Negative affectivity and social inhibition in cardiovascular disease: evaluating type-D personality and its assessment using item response theory. J. Psychosom. Res. 63(1), 27-39 (2007).
17. Denollet J. Type D personality. A potential risk factor refined. J. Psychosom. Res. 49(4), 255-266 (2000).
18. Schiffer AA, Pedersen SS, Widdershoven JW, Hendriks EH, Winter JB, Denollet J. The distressed (type D) personality is independently associated with impaired health status and increased depressive symptoms in chronic heart failure. Eur. J. Cardiovasc. Prev. Rehabil. 12, 341-346 (2005).
19. Honig A, Maes M. Psychoimmunology as common pathogenetic pathway in myocardial infarction, depression and cardiac death. Curr. Opin. Psychiatry 13, 661-664 (2000).
20. Schins A, Tulner D, Lousberg R et al. Inflammatory markers in depressed post-myocardial infarction patients. J. Psychiatr. Res. 39(2), 137-144 (2005); Erratum in: J. Psychiatr. Res. 39(6), 633 (2005).
21. Schins A, Crijns HJ, Brummer R-J, Wichers M, Lousberg R, Celis S, Honig A. Altered omega-3 polyunsaturated fatty acid status in depressed post-myocardial infarction patients. Acta Psychiatrica Scand. 115, 35-40 (2007).
22. 2A receptor as missing link? Psychosom. Med. 65, 729-737 (2003).
23. Schins A, Hamulyak K, Scharpé S et al. Whole blood serotonin and platelet activation in depressed post-myocardial infarction patients. Life Sci. 76, 637-650 (2004).
24. Schins A, van Kroonenburgh M, van Laere K et al. Increased cerebral 5-HT 2A receptor binding in depressed patients with myocardial infarction. Psychiatry Res. Neuroimaging 139, 155-163 (2005).
25. Nakatani D, Sato H, Sakata Y et al. Influence of serotonin transporter gene polymorphism on depressive symptoms and new cardiac events after acute myocardial infarction. Am. Heart J. 150, 652-658 (2005).
26. Otte C, McCaffery J, Ali S, Whooley MA. Association of a serotonin transporter polymorphism (5-HTTLPR) with depression, perceived stress, and norepinephrine in patients with coronary disease: the Heart and Soul Study. Am. J. Psychiatry 164, 1379-1384 (2007).
27. Maurer-Spurej E. Biomedicine and diseases: review; serotonin reuptake inhibitors and cardiovascular diseases: a platelet connection. Cell Mol. Life Sci. 62, 159-170(2005).
28. Strik JJ, Honig A, Lousberg R et al. Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial. Psychosom. Med. 62(6), 783-978 (2000).
29. Glassman AH, O'Connor CM, Califf RM et al.; for the Sertraline Antidepressant Heart Attack Randomized Trial Group. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 288, 701-709 (2002).
30. Writing Committee for the ENRICHD Investigators. Effects of treating depression and low perceived social support on clinical events after myocardial infarction. JAMA 289, 3106-3116 (2003).
31. Honig A, Kuyper AMG, Schene AH et al.; On behalf of the MIND-IT investigators. Treatment of post myocardial infarction depressive disorder: a randomized placebo controlled trial with mirtazapine. Pyschosom. Med. 69, 606-613 (2007).
32. Lespérance F, Frasure-Smith N, Koszycki D et al.; for the CREATE investigators. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary disease. JAMA 297, 367-379 (2007).
33. Roose SP, Laghrissi-Thode F, Kennedy JS et al. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA 279, 287-291 (1998).
34. Benazon NR, Mamdani MM, Coyne JC. Trends in the prescribing of antidepressants following acute myocardial infarction, 1993-2002. Psychosom. Med. 67, 916-920 (2005).